{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:24:38Z","timestamp":1790832278996,"version":"4.1.0"},"reference-count":155,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T00:00:00Z","timestamp":1545264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Several viruses cause pulmonary infections due to their shared tropism with cells of the respiratory tract. These respiratory problems due to viral infection become a public health concern due to rapid transmission through air\/aerosols or via direct-indirect contact with infected persons. In addition, the cross-species transmission causes alterations to viral genetic makeup thereby increasing the risk of emergence of pathogens with new and more potent infectivity. With the introduction of effective nucleic acid-based technologies, post translational gene silencing (PTGS) is being increasingly used to silence viral gene targets and has shown promising approach towards management of many viral infections. Since several host factors are also utilized by these viruses during various stages of infection, silencing these host factors can also serve as promising therapeutic tool. Several nucleic acid-based technologies such as short interfering RNAs (siRNA), antisense oligonucleotides, aptamers, deoxyribozymes (DNAzymes), and ribozymes have been studied and used against management of respiratory viruses. These therapeutic nucleic acids can be efficiently delivered through the airways. Studies have also shown efficacy of gene therapy in clinical trials against respiratory syncytial virus (RSV) as well as models of respiratory diseases including severe acute respiratory syndrome (SARS), measles and influenza. In this review, we have summarized some of the recent advancements made in the area of nucleic acid based therapeutics and highlighted the emerging roles of nucleic acids in the management of some of the severe respiratory viral infections. We have also focused on the methods of their delivery and associated challenges.<\/jats:p>","DOI":"10.3390\/jcm8010006","type":"journal-article","created":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T12:54:36Z","timestamp":1545310476000},"page":"6","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Advancements in Nucleic Acid Based Therapeutics against Respiratory Viral Infections"],"prefix":"10.3390","volume":"8","author":[{"given":"Kumari","family":"Asha","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Kumar","sequence":"additional","affiliation":[{"name":"Amity Institute of Virology and Immunology, Amity University, Noida 201303, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melvin","family":"Sanicas","sequence":"additional","affiliation":[{"name":"Sanofi Pasteur, Asia and JPAC Region, Singapore 257856, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement A.","family":"Meseko","sequence":"additional","affiliation":[{"name":"Regional Centre for Animal Influenza, National Veterinary Research Institute, Vom 930010, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Khanna","sequence":"additional","affiliation":[{"name":"Department of Respiratory Virology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi 110007, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2077-8501","authenticated-orcid":false,"given":"Binod","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,12,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s12038-008-0066-z","article-title":"Emerging influenza virus: A global threat","volume":"33","author":"Khanna","year":"2008","journal-title":"J. Biosci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s13337-012-0066-3","article-title":"Pandemic Influenza a H1N1 (2009) Virus: Lessons from the Past and Implications for the Future","volume":"23","author":"Khanna","year":"2012","journal-title":"Indian J. Virol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s12088-009-0064-3","article-title":"Pandemic swine influenza virus (H1N1): A threatening evolution","volume":"49","author":"Khanna","year":"2009","journal-title":"Indian J. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00705-018-3708-y","article-title":"The emerging influenza virus threat: Status and new prospects for its therapy and control","volume":"163","author":"Kumar","year":"2018","journal-title":"Arch. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1126\/science.1086478","article-title":"Transmission dynamics of the etiological agent of SARS in Hong Kong: Impact of public health interventions","volume":"300","author":"Riley","year":"2003","journal-title":"Science"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrmicro2147","article-title":"Coronaviruses post-SARS: Update on replication and pathogenesis","volume":"7","author":"Perlman","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3201\/eid2107.150421","article-title":"Highly Pathogenic Avian Influenza A(H5N1) Virus in Poultry, Nigeria, 2015","volume":"21","author":"Monne","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1038\/s41598-018-24371-6","article-title":"Evidence of exposure of domestic pigs to Highly Pathogenic Avian Influenza H5N1 in Nigeria","volume":"8","author":"Meseko","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3201\/eid1504.070159","article-title":"Avian influenza risk perception among poultry workers, Nigeria","volume":"15","author":"Fasina","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"546274","DOI":"10.1155\/2014\/546274","article-title":"Protective immunity based on the conserved hemagglutinin stalk domain and its prospects for universal influenza vaccine development","volume":"2014","author":"Khanna","year":"2014","journal-title":"BioMed Res. Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/CMR.11.3.430","article-title":"Respiratory syncytial virus vaccines","volume":"11","author":"Dudas","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1182\/blood.V92.3.712","article-title":"Nucleic acid therapeutics: State of the art and future prospects","volume":"92","author":"Gewirtz","year":"1998","journal-title":"Blood"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0169-409X(02)00046-7","article-title":"Prospects for cationic polymers in gene and oligonucleotide therapy against cancer","volume":"54","author":"Merdan","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"12754","DOI":"10.1073\/pnas.221450098","article-title":"Brain-specific expression of an exogenous gene after I.V. administration","volume":"98","author":"Shi","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1067\/mtc.2001.111204","article-title":"Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy","volume":"121","author":"Ehsan","year":"2001","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"16416","DOI":"10.1016\/S0021-9258(17)34023-1","article-title":"Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters","volume":"269","author":"Dean","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"8191","DOI":"10.1074\/jbc.274.12.8191","article-title":"Antisense oligonucleotides containing modified bases inhibit in vitro translation of Leishmania amazonensis mRNAs by invading the mini-exon hairpin","volume":"274","author":"Compagno","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"D497","DOI":"10.2741\/Macpherson","article-title":"Ribozymes in gene therapy of HIV-1","volume":"4","author":"Macpherson","year":"1999","journal-title":"Front. Biosci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1099\/vir.0.83650-0","article-title":"Sequence-specific cleavage of hepatitis C virus RNA by DNAzymes: Inhibition of viral RNA translation and replication","volume":"89","author":"Roy","year":"2008","journal-title":"J. Gen. Virol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2217\/fmb.14.94","article-title":"Gene silencing: A therapeutic approach to combat influenza virus infections","volume":"10","author":"Khanna","year":"2015","journal-title":"Future Microbiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/MMBR.67.4.657-685.2003","article-title":"RNA interference: Biology, mechanism, and applications","volume":"67","author":"Agrawal","year":"2003","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1126\/science.286.5441.950","article-title":"A species of small antisense RNA in posttranscriptional gene silencing in plants","volume":"286","author":"Hamilton","year":"1999","journal-title":"Science"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"Fire","year":"1998","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1166\/jbn.2014.1928","article-title":"SiRNA-based therapies for pulmonary diseases","volume":"10","author":"Koli","year":"2014","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2174\/187152608786734223","article-title":"RNA interference-based therapeutics: New strategies to fight infectious disease","volume":"8","author":"Wright","year":"2008","journal-title":"Infect. Disord. Drug Targets"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Bitko, V., and Barik, S. (2001). Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses. BMC Microbiol., 1.","DOI":"10.1186\/1471-2180-1-34"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejpb.2013.05.006","article-title":"Formulation of pH responsive peptides as inhalable dry powders for pulmonary delivery of nucleic acids","volume":"86","author":"Liang","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.1073\/pnas.0502067102","article-title":"Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung","volume":"102","author":"Thomas","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.virusres.2004.01.013","article-title":"Use of siRNAs to prevent and treat influenza virus infection","volume":"102","author":"Ge","year":"2004","journal-title":"Virus Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.antiviral.2015.04.017","article-title":"Expression of a single siRNA against a conserved region of NP gene strongly inhibits in vitro replication of different Influenza A virus strains of avian and swine origin","volume":"120","author":"Stoppani","year":"2015","journal-title":"Antivir. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/nm1280","article-title":"Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque","volume":"11","author":"Li","year":"2005","journal-title":"Nat. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"433","DOI":"10.18388\/abp.2014_1861","article-title":"Influenza A viruses of avian origin circulating in pigs and other mammals","volume":"61","author":"Urbaniak","year":"2014","journal-title":"Acta Biochim. Pol."},{"key":"ref_34","first-page":"15","article-title":"Clinical presentation of patients with seasonal influenza and pandemic influenza A (H1N1-2009) requiring hospitalisation","volume":"55","author":"Pati","year":"2013","journal-title":"Indian J. Chest Dis. Allied Sci."},{"key":"ref_35","first-page":"144","article-title":"Quantification of viral load in clinical specimens collected from different body sites of patients infected with influenza viruses","volume":"3","author":"Kumar","year":"2011","journal-title":"Int. J. Med. Med. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s13337-010-0005-0","article-title":"Diagnosis of Novel Pandemic Influenza Virus 2009 H1N1 in Hospitalized Patients","volume":"21","author":"Kumar","year":"2010","journal-title":"Indian J. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1093\/cid\/ciq011","article-title":"2009 Pandemic influenza A (H1N1) deaths among children\u2014United States, 2009\u20132010","volume":"52","author":"Cox","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1473-3099(12)70121-4","article-title":"Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: A modelling study","volume":"12","author":"Dawood","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2217\/fvl.13.18","article-title":"Influenza pandemics of 1918 and 2009: A comparative account","volume":"8","author":"Khanna","year":"2013","journal-title":"Future Virol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/oxfordjournals.epirev.a017917","article-title":"Emerging infections: Pandemic influenza","volume":"18","author":"Glezen","year":"1996","journal-title":"Epidemiol. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Saxena, S.K. (2018). Preventing zoonotic influenza. Influenza Therapeutics and Challenges, IntechOpen.","DOI":"10.5772\/intechopen.71939"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMra050740","article-title":"Neuraminidase inhibitors for influenza","volume":"353","author":"Moscona","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1586\/14787210.4.5.795","article-title":"Resistance to anti-influenza drugs: Adamantanes and neuraminidase inhibitors","volume":"4","author":"Hurt","year":"2006","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/irv.12047","article-title":"Influenza neuraminidase inhibitors: Antiviral action and mechanisms of resistance","volume":"7","year":"2013","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1473-3099(11)70318-8","article-title":"Antiviral resistance during the 2009 influenza A H1N1 pandemic: Public health, laboratory, and clinical perspectives","volume":"12","author":"Hurt","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1073\/pnas.0308308100","article-title":"Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing","volume":"101","author":"Li","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1743-422X-8-44","article-title":"Identification of novel conserved functional motifs across most Influenza A viral strains","volume":"8","author":"ElHefnawi","year":"2011","journal-title":"Virol. J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1073\/pnas.0437841100","article-title":"RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription","volume":"100","author":"Ge","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"8676","DOI":"10.1073\/pnas.0402486101","article-title":"Inhibition of influenza virus production in virus-infected mice by RNA interference","volume":"101","author":"Ge","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"8682","DOI":"10.1073\/pnas.0402630101","article-title":"Protection against lethal influenza virus challenge by RNA interference in vivo","volume":"101","author":"Tompkins","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1089\/nat.2012.0359","article-title":"Small interfering RNA targeting the nonstructural gene 1 transcript inhibits influenza A virus replication in experimental mice","volume":"22","author":"Rajput","year":"2012","journal-title":"Nucleic Acid Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.antiviral.2010.05.001","article-title":"Potent inhibition of influenza virus replication with novel siRNA-chimeric-ribozyme constructs","volume":"87","author":"Kumar","year":"2010","journal-title":"Antivir. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.antiviral.2007.07.002","article-title":"Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice","volume":"76","author":"Zhou","year":"2007","journal-title":"Antivir. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm1191","article-title":"Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7","volume":"11","author":"Hornung","year":"2005","journal-title":"Nat. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nbt1081","article-title":"Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA","volume":"23","author":"Judge","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"11911","DOI":"10.1128\/JVI.01565-06","article-title":"Role of ran binding protein 5 in nuclear import and assembly of the influenza virus RNA polymerase complex","volume":"80","author":"Deng","year":"2006","journal-title":"J. Virol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12016-013-8368-9","article-title":"Respiratory syncytial virus\u2014A comprehensive review","volume":"45","author":"Borchers","year":"2013","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e1474","DOI":"10.1542\/peds.2014-2742","article-title":"Clinical practice guideline: The diagnosis, management, and prevention of bronchiolitis","volume":"134","author":"Ralston","year":"2014","journal-title":"Pediatrics"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1128\/CMR.13.3.371","article-title":"Respiratory syncytial virus infection in adults","volume":"13","author":"Falsey","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_60","first-page":"77","article-title":"Respiratory syncytial virus infection in elderly and high-risk adults","volume":"31","author":"Falsey","year":"2005","journal-title":"Exp. Lung Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"B209","DOI":"10.1016\/j.vaccine.2012.11.106","article-title":"Strategic priorities for respiratory syncytial virus (RSV) vaccine development","volume":"31","author":"Anderson","year":"2013","journal-title":"Vaccine"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.antiviral.2007.11.009","article-title":"Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV)","volume":"77","author":"DeVincenzo","year":"2008","journal-title":"Antivir. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nm1164","article-title":"Inhibition of respiratory viruses by nasally administered siRNA","volume":"11","author":"Bitko","year":"2005","journal-title":"Nat. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"8800","DOI":"10.1073\/pnas.0912186107","article-title":"A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus","volume":"107","author":"DeVincenzo","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.healun.2015.08.012","article-title":"ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients","volume":"35","author":"Gottlieb","year":"2016","journal-title":"J. Heart Lung Transplant."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00109-007-0179-0","article-title":"RNAi-dependent and -independent antiviral phenotypes of chromosomally integrated shRNA clones: Role of VASP in respiratory syncytial virus growth","volume":"85","author":"Musiyenko","year":"2007","journal-title":"J. Mol. Med. (Berl.)"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1128\/JVI.01271-09","article-title":"Mutational analysis reveals a noncontractile but interactive role of actin and profilin in viral RNA-dependent RNA synthesis","volume":"83","author":"Harpen","year":"2009","journal-title":"J. Virol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Bitko, V., Oldenburg, A., Garmon, N.E., and Barik, S. (2003). Profilin is required for viral morphogenesis, syncytium formation, and cell-specific stress fiber induction by respiratory syncytial virus. BMC Microbiol., 3.","DOI":"10.1186\/1471-2180-3-9"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1128\/JVI.74.2.669-675.2000","article-title":"Profilin is required for optimal actin-dependent transcription of respiratory syncytial virus genome RNA","volume":"74","author":"Burke","year":"2000","journal-title":"J. Virol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"7523","DOI":"10.1128\/JVI.78.14.7523-7527.2004","article-title":"Inhibition of severe acute respiratory syndrome virus replication by small interfering RNAs in mammalian cells","volume":"78","author":"Wang","year":"2004","journal-title":"J. Virol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.antiviral.2004.09.005","article-title":"Inhibition of SARS-CoV replication by siRNA","volume":"65","author":"Wu","year":"2005","journal-title":"Antivir. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0014-5793(04)00087-0","article-title":"Silencing SARS-CoV Spike protein expression in cultured cells by RNA interference","volume":"560","author":"Zhang","year":"2004","journal-title":"FEBS Lett."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-1-59745-191-8_11","article-title":"Application of siRNA against SARS in the rhesus macaque model","volume":"442","author":"Tang","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1128\/AAC.01598-05","article-title":"Inhibition of human coronavirus NL63 infection at early stages of the replication cycle","volume":"50","author":"Pyrc","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.antiviral.2010.08.002","article-title":"Inhibition of adenovirus infections by siRNA-mediated silencing of early and late adenoviral gene functions","volume":"88","author":"Eckstein","year":"2010","journal-title":"Antivir. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0168-6445(03)00020-2","article-title":"Ribozymes: Recent advances in the development of RNA tools","volume":"27","year":"2003","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12033-011-9437-z","article-title":"Nucleic acid-mediated cleavage of M1 gene of influenza A virus is significantly augmented by antisense molecules targeted to hybridize close to the cleavage site","volume":"51","author":"Kumar","year":"2012","journal-title":"Mol. Biotechnol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/jmv.1890420411","article-title":"Ribozyme mediated destruction of influenza A virus in vitro and in vivo","volume":"42","author":"Tang","year":"1994","journal-title":"J. Med. Virol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Motard, J., Rouxel, R., Paun, A., von Messling, V., Bisaillon, M., and Perreault, J.P. (2011). A novel ribozyme-based prophylaxis inhibits influenza A virus replication and protects from severe disease. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0027327"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.1073\/pnas.95.13.7327","article-title":"Effective inhibition of influenza virus production in cultured cells by external guide sequences and ribonuclease P","volume":"95","author":"Altman","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0166-3542(99)00015-7","article-title":"Inhibition of influenza A virus reproduction by a ribozyme targeted against PB1 mRNA","volume":"42","author":"Lazarev","year":"1999","journal-title":"Antivir. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"9679","DOI":"10.1128\/JVI.73.11.9679-9682.1999","article-title":"Rescue of influenza A virus from recombinant DNA","volume":"73","author":"Fodor","year":"1999","journal-title":"J. Virol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000215946","article-title":"Development of a chimeric DNA-RNA hammerhead ribozyme targeting SARS virus","volume":"52","author":"Fukushima","year":"2009","journal-title":"Intervirology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1093\/nar\/24.15.3010","article-title":"Selection of the best target site for ribozyme-mediated cleavage within a fusion gene for adenovirus E1A-associated 300 kDa protein (p300) and luciferase","volume":"24","author":"Kawasaki","year":"1996","journal-title":"Nucleic Acids Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature01406","article-title":"DNA in a material world","volume":"421","author":"Seeman","year":"2003","journal-title":"Nature"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00080-6","article-title":"The delivery of antisense therapeutics","volume":"44","author":"Akhtar","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1021\/ar900052y","article-title":"Deoxyribozymes: Selection design and serendipity in the development of DNA catalysts","volume":"42","author":"Silverman","year":"2009","journal-title":"Acc. Chem. Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1021\/ja7111965","article-title":"DNA and RNA can be equally efficient catalysts for carbon-carbon bond formation","volume":"130","author":"Chandra","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"ref_89","first-page":"WMC004415","article-title":"DNAzyme mediated post-transcriptional gene silencing: A novel therapeutic approach","volume":"4","author":"Kumar","year":"2013","journal-title":"WebmedCent. Mol. Biol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0014-5793(00)01974-8","article-title":"Inhibition of influenza virus replication in cultured cells by RNA-cleaving DNA enzyme","volume":"481","author":"Toyoda","year":"2000","journal-title":"FEBS Lett."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0014-5793(04)00073-0","article-title":"A new modified DNA enzyme that targets influenza virus A mRNA inhibits viral infection in cultured cells","volume":"560","author":"Takahashi","year":"2004","journal-title":"FEBS Lett."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1089\/nat.2013.0432","article-title":"Sequence-specific cleavage of BM2 gene transcript of influenza B virus by 10-23 catalytic motif containing DNA enzymes significantly inhibits viral RNA translation and replication","volume":"23","author":"Kumar","year":"2013","journal-title":"Nucleic Acid Ther."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s12033-015-9876-z","article-title":"Potent Intracellular Knock-Down of Influenza A Virus M2 Gene Transcript by DNAzymes Considerably Reduces Viral Replication in Host Cells","volume":"57","author":"Kumar","year":"2015","journal-title":"Mol. Biotechnol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.antiviral.2006.02.011","article-title":"Inhibition of respiratory syncytial virus in cultured cells by nucleocapsid gene targeted deoxyribozyme (DNAzyme)","volume":"71","author":"Xie","year":"2006","journal-title":"Antivir. Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.virusres.2007.06.017","article-title":"Inhibition of respiratory syncytial virus of subgroups A and B using deoxyribozyme DZ1133 in mice","volume":"130","author":"Zhou","year":"2007","journal-title":"Virus Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/jgm.1111","article-title":"An efficient RNA-cleaving DNA enzyme can specifically target the 5\u2032-untranslated region of severe acute respiratory syndrome associated coronavirus (SARS-CoV)","volume":"9","author":"Wu","year":"2007","journal-title":"J. Gene Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev.pharmtox.010909.105654","article-title":"RNA targeting therapeutics: Molecular mechanisms of antisense oligonucleotides as a therapeutic platform","volume":"50","author":"Bennett","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1073\/pnas.75.1.280","article-title":"Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide","volume":"75","author":"Zamecnik","year":"1978","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1073\/pnas.75.1.285","article-title":"Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide","volume":"75","author":"Stephenson","year":"1978","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2174\/157489110793348767","article-title":"Recent patents on nucleic acid-based antiviral therapeutics","volume":"5","author":"Mishra","year":"2010","journal-title":"Recent Pat. Antiinfect. Drug Discov."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0014-5793(90)80039-L","article-title":"A new class of antivirals: Antisense oligonucleotides combined with a hydrophobic substituent effectively inhibit influenza virus reproduction and synthesis of virus-specific proteins in MDCK cells","volume":"259","author":"Kabanov","year":"1990","journal-title":"FEBS Lett."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bbrc.2007.10.196","article-title":"Inhibition of highly pathogenic avian H5N1 influenza virus replication by RNA oligonucleotides targeting NS1 gene","volume":"365","author":"Wu","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1099\/vir.0.83449-0","article-title":"Morpholino oligomers targeting the PB1 and NP genes enhance the survival of mice infected with highly pathogenic influenza A H7N7 virus","volume":"89","author":"Gabriel","year":"2008","journal-title":"J. Gen. Virol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/135965350801300112","article-title":"In vitro and in vivo protection against the highly pathogenic H5N1 influenza virus by an antisense phosphorothioate oligonucleotide","volume":"13","author":"Duan","year":"2008","journal-title":"Antivir. Ther."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s00705-008-0067-0","article-title":"Inhibition of influenza A H3N8 virus infections in mice by morpholino oligomers","volume":"153","author":"Lupfer","year":"2008","journal-title":"Arch. Virol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s12033-013-9670-8","article-title":"Cross-protective effect of antisense oligonucleotide developed against the common 3\u2032 NCR of influenza A virus genome","volume":"55","author":"Kumar","year":"2013","journal-title":"Mol. Biotechnol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00705-009-0380-2","article-title":"Oligonucleotides derived from the packaging signal at the 5\u2032 end of the viral PB2 segment specifically inhibit influenza virus in vitro","volume":"154","author":"Giannecchini","year":"2009","journal-title":"Arch. Virol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.antiviral.2011.06.013","article-title":"Packaging signals in the 5\u2032-ends of influenza virus PA, PB1, and PB2 genes as potential targets to develop nucleic-acid based antiviral molecules","volume":"92","author":"Giannecchini","year":"2011","journal-title":"Antivir. Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/nat.2016.0619","article-title":"Antisense Oligonucleotides Targeting Influenza A Segment 8 Genomic RNA Inhibit Viral Replication","volume":"26","author":"Lenartowicz","year":"2016","journal-title":"Nucleic Acid Ther."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0166-3542(96)01015-7","article-title":"Inhibition of respiratory syncytial virus replication by antisense oligodeoxyribonucleotides","volume":"33","author":"Jairath","year":"1997","journal-title":"Antivir. Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/mt.2008.81","article-title":"Inhibition of respiratory syncytial virus infections with morpholino oligomers in cell cultures and in mice","volume":"16","author":"Lai","year":"2008","journal-title":"Mol. Ther."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/978-0-387-33012-9_103","article-title":"Inhibition and escape of SARS-CoV treated with antisense morpholino oligomers","volume":"581","author":"Neuman","year":"2006","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"9665","DOI":"10.1128\/JVI.79.15.9665-9676.2005","article-title":"Inhibition, escape, and attenuated growth of severe acute respiratory syndrome coronavirus treated with antisense morpholino oligomers","volume":"79","author":"Neuman","year":"2005","journal-title":"J. Virol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2011.04.009","article-title":"Interference of ribosomal frameshifting by antisense peptide nucleic acids suppresses SARS coronavirus replication","volume":"91","author":"Ahn","year":"2011","journal-title":"Antivir. Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.2200121","article-title":"Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase","volume":"249","author":"Tuerk","year":"1990","journal-title":"Science"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.2174\/1381612822666160203142513","article-title":"Aptamers to Hemagglutinin: A Novel Tool for Influenza Virus Recognition and Neutralization","volume":"22","author":"Zavyalova","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ab.2005.04.013","article-title":"Selection of RNA aptamers against human influenza virus hemagglutinin using surface plasmon resonance","volume":"342","author":"Misono","year":"2005","journal-title":"Anal. Biochem."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/nass\/49.1.85","article-title":"Selection of RNA-aptamer against human influenza B virus","volume":"49","author":"Gopinath","year":"2005","journal-title":"Nucleic Acids Symp. Ser. (Oxf.)"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1099\/vir.0.81508-0","article-title":"An RNA aptamer that distinguishes between closely related human influenza viruses and inhibits haemagglutinin-mediated membrane fusion","volume":"87","author":"Gopinath","year":"2006","journal-title":"J. Gen. Virol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bios.2012.10.038","article-title":"Hydrogel based QCM aptasensor for detection of avian influenza virus","volume":"42","author":"Wang","year":"2013","journal-title":"Biosens. Bioelectron."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bbrc.2013.11.041","article-title":"Selection of DNA aptamers that bind to influenza A viruses with high affinity and broad subtype specificity","volume":"443","author":"Shiratori","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"12506","DOI":"10.3390\/s120912506","article-title":"A SPR aptasensor for detection of avian influenza virus H5N1","volume":"12","author":"Bai","year":"2012","journal-title":"Sensors (Basel)"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"18565","DOI":"10.3390\/s150818565","article-title":"An Impedance Aptasensor with Microfluidic Chips for Specific Detection of H5N1 Avian Influenza Virus","volume":"15","author":"Lum","year":"2015","journal-title":"Sensors (Basel)"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bios.2016.06.064","article-title":"Highly sensitive sandwich-type SPR based detection of whole H5Nx viruses using a pair of aptamers","volume":"86","author":"Nguyen","year":"2016","journal-title":"Biosens. Bioelectron."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"48410","DOI":"10.1074\/jbc.M409059200","article-title":"A DNA aptamer prevents influenza infection by blocking the receptor binding region of the viral hemagglutinin","volume":"279","author":"Jeon","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Musafia, B., Oren-Banaroya, R., and Noiman, S. (2014). Designing anti-influenza aptamers: Novel quantitative structure activity relationship approach gives insights into aptamer-virus interaction. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0097696"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.antiviral.2013.09.004","article-title":"Single-stranded DNA aptamer that specifically binds to the influenza virus NS1 protein suppresses interferon antagonism","volume":"100","author":"Woo","year":"2013","journal-title":"Antivir. Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1128\/AAC.00306-15","article-title":"Cross-protection of influenza A virus infection by a DNA aptamer targeting the PA endonuclease domain","volume":"59","author":"Yuan","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1038\/mtna.2016.20","article-title":"Inhibition of Influenza Virus Replication by DNA Aptamers Targeting a Cellular Component of Translation Initiation","volume":"5","author":"Rodriguez","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cyto.2015.07.002","article-title":"The catcher in the RIG-I","volume":"76","author":"Weber","year":"2015","journal-title":"Cytokine"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1093\/nar\/gkr1098","article-title":"5\u2032-Triphosphate-RNA-independent activation of RIG-I via RNA aptamer with enhanced antiviral activity","volume":"40","author":"Hwang","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1039\/b906788d","article-title":"RNA aptamer-based sensitive detection of SARS coronavirus nucleocapsid protein","volume":"134","author":"Ahn","year":"2009","journal-title":"Analyst"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jbiosc.2011.08.014","article-title":"Novel system for detecting SARS coronavirus nucleocapsid protein using an ssDNA aptamer","volume":"112","author":"Cho","year":"2011","journal-title":"J. Biosci. Bioeng."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.bbrc.2007.12.020","article-title":"Isolation of inhibitory RNA aptamers against severe acute respiratory syndrome (SARS) coronavirus NTPase\/Helicase","volume":"366","author":"Jang","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1002\/cbic.200800491","article-title":"Differential inhibitory activities and stabilisation of DNA aptamers against the SARS coronavirus helicase","volume":"9","author":"Shum","year":"2008","journal-title":"ChemBioChem"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"42794","DOI":"10.1038\/srep42794","article-title":"Aptamers for respiratory syncytial virus detection","volume":"7","author":"Percze","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Huang, D.T., Lu, C.Y., Shao, P.L., Chang, L.Y., Wang, J.Y., Chang, Y.H., Lai, M.J., Chi, Y.H., and Huang, L.M. (2017). In vivo inhibition of influenza A virus replication by RNA interference targeting the PB2 subunit via intratracheal delivery. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0174523"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3390\/v2071448","article-title":"siRNA for Influenza Therapy","volume":"2","author":"Barik","year":"2010","journal-title":"Viruses"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1007\/s00705-011-1087-8","article-title":"Inhibition of influenza A virus replication by RNA interference targeted against the PB1 subunit of the RNA polymerase gene","volume":"156","author":"Li","year":"2011","journal-title":"Arch. Virol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.bbrc.2009.09.039","article-title":"Inhibition of highly pathogenic avian influenza virus H5N1 replication by the small interfering RNA targeting polymerase A gene","volume":"390","author":"Zhang","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1479-0556-5-4","article-title":"Respiratory syncytial virus infection in Fischer 344 rats is attenuated by short interfering RNA against the RSV-NS1 gene","volume":"5","author":"Kong","year":"2007","journal-title":"Genet. Vaccines Ther."},{"key":"ref_142","unstructured":"Meyer, M. (2011). Ribozymes as Antivirals for Respiratory Syncytial Virus. [Ph.D. Thesis, The University of Queensland]."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/nass\/nrp144","article-title":"Inhibition of influenza virus by baculovirus-mediated shRNA","volume":"53","author":"Suzuki","year":"2009","journal-title":"Nucleic Acids Symp. Ser. (Oxf.)"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/nbt1161","article-title":"Activation of the mammalian immune system by siRNAs","volume":"23","author":"Marques","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.addr.2007.03.006","article-title":"RNA interference and innate immunity","volume":"59","author":"Sioud","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"De Ley, M. (2012). shRNA-Induced Interferon-Stimulated Gene Analysis. Cytokine Protocols, Humana Press.","DOI":"10.1007\/978-1-61779-439-1"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3389\/fimmu.2017.00331","article-title":"RNA Interference-Induced Innate Immunity, Off-Target Effect, or Immune Adjuvant?","volume":"8","author":"Meng","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nrd837","article-title":"Nucleic-acid therapeutics: Basic principles and recent applications","volume":"1","author":"Opalinska","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.2174\/092986711797189600","article-title":"Nucleic Acid Aptamers: Clinical Applications and Promising New Horizons","volume":"18","author":"Ni","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4103\/0970-0218.94028","article-title":"Age-Sex Distribution and Seasonality Pattern among Influenza Virus Infected Patients in Delhi, 2009\u20132010","volume":"37","author":"Kumar","year":"2012","journal-title":"Indian J. Community Med."},{"key":"ref_151","first-page":"175","article-title":"Comparison of various immunoassay kits for rapid screening of pandemic influenza H1N1-2009 viruses","volume":"2","author":"Kumar","year":"2010","journal-title":"J. Public Health Epidemiol."},{"key":"ref_152","first-page":"1346","article-title":"Comparative reproducibility of SYBR Green I and TaqMan real-time PCR chemistries for the analysis of matrix and hemagglutinin genes of Influenza A viruses","volume":"4","author":"Kumar","year":"2012","journal-title":"Int. J. Collab. Res. Intern. Med. Public Health"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Kawai, Y., Kimura, Y., Lezhava, A., Kanamori, H., Usui, K., Hanami, T., Soma, T., Morlighem, J.E., Saga, S., and Ishizu, Y. (2012). One-step detection of the 2009 pandemic influenza A(H1N1) virus by the RT-SmartAmp assay and its clinical validation. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0030236"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.antiviral.2011.10.021","article-title":"A conserved matrix epitope based DNA vaccine protects mice against influenza A virus challenge","volume":"93","author":"Kumar","year":"2012","journal-title":"Antivir. Res."},{"key":"ref_155","unstructured":"Clinicaltrials.gov (2018, October 08). A Safety and Immunogenicity Study of Intranasal Sendai Virus Vectored Respiratory Syncytial Virus (SeVRSV) Vaccine in Healthy Adults, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT03473002."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/8\/1\/6\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:35:12Z","timestamp":1760196912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/8\/1\/6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,20]]},"references-count":155,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1]]}},"alternative-id":["jcm8010006"],"URL":"https:\/\/doi.org\/10.3390\/jcm8010006","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,20]]}}}